ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

GERALDINE HAUGHTON NURSE PRACTITIONER

451 CLARKSON AVE GERIATRICS CLINIC SUITE 1E RM 65

Brooklyn | New York | 11203

(718) 245-5205

Incorrect Info?
Search this name in Dollars for Docs »

At A Glance: This Prescriber in 2012

Nurse Practitioner, Gerontology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,819Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 56

$407K Total Retail Price of All Prescriptions

Rank: 3 out of 56

301 Patients Receiving at Least One Drug in Part D
99%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 301 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 8,814 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
SIMVASTATIN 730 730 1 3
AMLODIPINE BESYLATE 603 603 2 6
NIFEDIPINE ER 538 538 3 25
HYDROCHLOROTHIAZIDE 451 451 4 10
FUROSEMIDE 310 310 5 2
FOSINOPRIL SODIUM 310 310 5 21
CRESTOR 288 288 7 23
METOPROLOL TARTRATE 279 279 8 8
JANUVIA 239 239 9 33
ENALAPRIL MALEATE 198 195 10 27
ALENDRONATE SODIUM 197 197 11 18
METFORMIN HCL 183 183 12 12
LABETALOL HCL 167 167 13 77
METOPROLOL SUCCINATE 155 155 14 14
GLIPIZIDE XL 147 147 15 83
GLIPIZIDE ER 147 147 15 83
LOSARTAN POTASSIUM 139 139 17 24
NEXIUM 135 135 18 29
NIFEDICAL XL 127 127 19 94
LOSARTAN-HYDROCHLOROTHIAZIDE 118 118 20 46
CLOPIDOGREL 111 111 21 34
LANTUS SOLOSTAR 108 108 22 76
CARVEDILOL 93 93 23 39
DONEPEZIL HCL 85 85 24 13
PLAVIX 84 84 25 53
ATORVASTATIN CALCIUM 83 83 26 16
LEVOTHYROXINE SODIUM 79 79 27 4
ENALAPRIL-HYDROCHLOROTHIAZIDE 77 77 28 113
LISINOPRIL 75 75 29 7
OMEPRAZOLE 73 73 30 5
LANTUS 69 69 31 26
DIOVAN 69 69 31 43
POLYETHYLENE GLYCOL 3350 64 64 33 70
RANITIDINE HCL 64 62 33 31
CHLORTHALIDONE 62 62 35 75
PRAVASTATIN SODIUM 61 61 36 59
INSULIN SYRINGE 59 59 37 132
KLOR-CON 8 59 59 37 132
GLYBURIDE-METFORMIN HCL 58 58 R 39 135
PRANDIN 57 57 40 87
SINGLE USE SWAB 52 52 41 149
ALCOHOL SWABS 52 52 41 149
ISOSORBIDE MONONITRATE ER 51 51 43 47
MIRTAZAPINE 50 50 44 15
POTASSIUM CHLORIDE 50 50 44 22
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.